GSK sees blockbuster potential in targeted cancer therapy after promising early data

GSK sees blockbuster potential in targeted cancer therapy after promising early data
Source link

GSK sees blockbuster potential in targeted cancer therapy after promising early data
Source link
Price: Ask for Quote Based on Requirement Welcome to Kenny Loh Holistic Legacy Planning. Securing your family’s future is a journey, not a single transaction. As a certified estate planner, I provide a comprehensive, four-step approach designed to organize your wealth, protect your beneficiaries, and ensure your legacy is passed on exactly as you intend….
Welcome to the MAY edition of my DivGro 2.0 newsletter! This edition comes in two parts because I have more transactions to cover than I normally do. Part 1 covers the April market recap and an overview of my DivGro portfolio, including April’s sell transactions. Part 2 covers my April buy transactions and presents this month’s top-10…
Rallis India, a Tata Enterprise, on Friday reported a 54.16 per cent on-year decline in net profit to Rs 11 crore for the quarter ended December 31, 2024. The company’s net profit stood at Rs 24 crore during the corresponding period of the previous financial year, Rallis India said in a regulatory filing. Revenue from…
On 11 February, Tractor Supply (TSCO) increased its dividend by 4.35%, from 23¢ to 24¢ per share. The dividend is payable on 10 March to shareholders of record on 24 February. TSCO’s contribution to DivGro’s projected annual dividend income will increase by $11 to $264. I own 275 shares of TSCO at an average cost basis of $41.22 per share….
The current section of the “Analysis” series covers Abbott India Ltd, a part of Abbott Group, USA. The company is a leading pharmaceutical company in India with leading brands like Thyronorm, Digene, Cremafin, Brufen, and Duphaston among many others. To benefit the maximum from this article, an investor should focus on the analysis process instead…
Investing.com – Spain stocks were higher after the close on Wednesday, as gains in the , and sectors led shares higher. At the close in Madrid, the added 0.33%. The best performers of the session on the were Sacyr SA (BME:), which rose 1.96% or 0.06 points to trade at 3.12 at the close. Meanwhile,…